Clinical Trial Update: Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating CKD-810 in combination with Taxotere (docetaxel) for advanced solid cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Cancers

Drugs mentioned

• CKD-810
• Taxotere (docetaxel)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Advanced Solid Cancers | Phase 1 | Status: COMPLETED